Search research articles
Contact Us
Filters
Showing results (1-10 of 92) with videos related to
Page
of 10
Sort By:
Expert Opinion on Pharmacotherapy
|
May 31, 2002
Assessing outcomes in palliative chemotherapy
Emma Cattell, Ana Arance, Mark Middleton
Cells
|
September 28, 2021
Molecular Markers and Targets in Melanoma
Cristina Teixido, Paola Castillo, Clara Martinez-Vila, et al.
Immunotherapy
|
April 28, 2021
Safe anti-programmed cell death-1 rechallenge with antibody switching after immune-related adverse events: brief communication
Francisco Aya, E Azucena González-Navarro, Clara Martínez, et al.
Future Oncology (London, England)
|
September 2, 2016
Ipilimumab after progression on anti-PD-1 treatment in advanced melanoma
Francisco Aya, Lydia Gaba, Iván Victoria, et al.
Immunotherapy
|
April 27, 2016
Pembrolizumab in a BRAF-mutant metastatic melanoma patient following a severe immune-related adverse event with ipilimumab
Francisco Aya, Aranzazu Fernández-Martínez, Lydia Gaba, et al.
International Journal of Molecular Sciences
|
September 14, 2024
Lymphocyte T Subsets and Outcome of Immune Checkpoint Inhibitors in Melanoma Patients: An Oncologist's Perspective on Current Knowledge
Clara Martínez-Vila, Europa Azucena González-Navarro, Cristina Teixido, et al.
Exploration of Targeted Anti-Tumor Therapy
|
September 1, 2022
Implementation of an NGS panel for clinical practice in paraffin-embedded tissue samples from locally advanced and metastatic melanoma patients
Paola Castillo, Marta Marginet, Pedro Jares, et al.
Cell Reports
|
April 13, 2024
Genomic deletions explain the generation of alternative BRAF isoforms conferring resistance to MAPK inhibitors in melanoma
Francisco Aya, Pablo Lanuza-Gracia, Abel González-Pérez, et al.
International Journal of Molecular Sciences
|
January 25, 2025
Detection of Circulating Tumor DNA in Liquid Biopsy: Current Techniques and Potential Applications in Melanoma
Clara Martínez-Vila, Cristina Teixido, Francisco Aya, et al.
Acta Dermato-Venereologica
|
May 18, 2021
Initial Stage of Cutaneous Primary Melanoma Plays a Key Role in the Pattern and Timing of Disease Recurrence
Sümeyre Seda Ertekin, Sebastian Podlipnik, Constanza Riquelme-Mc Loughlin, et al.
Page
of 10
Search research articles
Search
Showing results (1-10 of 92) with videos related to
Sort By:
Page
of 10
Expert Opinion on Pharmacotherapy
|
May 31, 2002
Assessing outcomes in palliative chemotherapy
Emma Cattell, Ana Arance, Mark Middleton
Cells
|
September 28, 2021
Molecular Markers and Targets in Melanoma
Cristina Teixido, Paola Castillo, Clara Martinez-Vila, et al.
Immunotherapy
|
April 28, 2021
Safe anti-programmed cell death-1 rechallenge with antibody switching after immune-related adverse events: brief communication
Francisco Aya, E Azucena González-Navarro, Clara Martínez, et al.
Future Oncology (London, England)
|
September 2, 2016
Ipilimumab after progression on anti-PD-1 treatment in advanced melanoma
Francisco Aya, Lydia Gaba, Iván Victoria, et al.
Immunotherapy
|
April 27, 2016
Pembrolizumab in a BRAF-mutant metastatic melanoma patient following a severe immune-related adverse event with ipilimumab
Francisco Aya, Aranzazu Fernández-Martínez, Lydia Gaba, et al.
International Journal of Molecular Sciences
|
September 14, 2024
Lymphocyte T Subsets and Outcome of Immune Checkpoint Inhibitors in Melanoma Patients: An Oncologist's Perspective on Current Knowledge
Clara Martínez-Vila, Europa Azucena González-Navarro, Cristina Teixido, et al.
Exploration of Targeted Anti-Tumor Therapy
|
September 1, 2022
Implementation of an NGS panel for clinical practice in paraffin-embedded tissue samples from locally advanced and metastatic melanoma patients
Paola Castillo, Marta Marginet, Pedro Jares, et al.
Cell Reports
|
April 13, 2024
Genomic deletions explain the generation of alternative BRAF isoforms conferring resistance to MAPK inhibitors in melanoma
Francisco Aya, Pablo Lanuza-Gracia, Abel González-Pérez, et al.
International Journal of Molecular Sciences
|
January 25, 2025
Detection of Circulating Tumor DNA in Liquid Biopsy: Current Techniques and Potential Applications in Melanoma
Clara Martínez-Vila, Cristina Teixido, Francisco Aya, et al.
Acta Dermato-Venereologica
|
May 18, 2021
Initial Stage of Cutaneous Primary Melanoma Plays a Key Role in the Pattern and Timing of Disease Recurrence
Sümeyre Seda Ertekin, Sebastian Podlipnik, Constanza Riquelme-Mc Loughlin, et al.
Page
of 10